← Leaderboards
Marinella Temprosa
George Washington University
$73,833,703
Attributed
$97,689,699
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $35.2M · FY2013–25$50M$37.5M$25M$12.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$164,211,266 · 9
By mechanism
U19$118,188,263 · 5
U01$37,415,074 · 2
R24$6,502,401 · 1
U24$2,105,528 · 1
Top collaborators
- Jose A Luchsinger8 shared
- Michael Dean Larsen7 shared
- David M Nathan6 shared
- Loretta Dipietro4 shared
- Kathleen Ann Jablonski4 shared
- Andres Cardenas1 shared
- Amanda Derryck Castel1 shared
- Abby Fleisch1 shared
Most similar at George Washington University
Same institution · by research overlap
- Rebecca Gersnoviez Clifton$95,055,095
- Elizabeth A Thom$177,996,531
- Scott Evans$2,499,873
- Kathleen Ann Jablonski$14,110,413
- Cora Ann Buckley Macpherson$655,400
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposOutcome StudyNon-Insulin-Dependent Diabetes MellitusDiabetes Prevention ProgramBiometryPrediabetes SyndromeProgramsWashingtonReportingUniversitiesPersonsMeasurementOperationCohortParticipantS Disease Related DementiaMetabolicPhenotypePlacebosLife StyleEventEpidemiologyMetforminPhysical Function
Grant awards (32)
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$15,462,979
U19 · FY2025 · AG
Clinical Operations and Procedures Core$11,768,382
U19 · FY2025 · AG · contact PI
The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DC$6,502,401
R24 · FY2025 · AI
Biostatistics and Data Infrastructure core$1,110,997
U19 · FY2025 · AG · contact PI
Metabolic Dysregulation and Cancer Risk Program: Coordinating Center$308,215
U24 · FY2025 · CA · contact PI
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,500,642
U19 · FY2024 · AG
Clinical Operations and Procedures Core$11,920,847
U19 · FY2024 · AG · contact PI
Impact of environmental toxicants on AD and ADRD risk in the Diabetes Prevention Program Outcomes study AD/ADRD project$2,533,483
U01 · FY2024 · AG
Biostatistics and Data Infrastructure core$920,594
U19 · FY2024 · AG · contact PI
Metabolic Dysregulation and Cancer Risk Program: Coordinating Center$571,267
U24 · FY2024 · CA · contact PI
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$250,000
U19 · FY2024 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,850,168
U19 · FY2023 · AG
Clinical Operations and Procedures Core$12,461,651
U19 · FY2023 · AG · contact PI
Biostatistics and Data Infrastructure core$687,559
U19 · FY2023 · AG · contact PI
Metabolic Dysregulation and Cancer Risk Program: Coordinating Center$600,823
U24 · FY2023 · CA · contact PI
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$250,000
U19 · FY2023 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,957,778
U19 · FY2022 · AG
Clinical Operations and Procedures Core$12,055,505
U19 · FY2022 · AG · contact PI
Biostatistics and Data Infrastructure core$741,161
U19 · FY2022 · AG · contact PI
Metabolic Dysregulation and Cancer Risk Program: Coordinating Center$625,223
U24 · FY2022 · CA · contact PI
DPPOS AD/ADRD Health Economics Evaluation$250,000
U19 · FY2022 · AG
22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) â Biostatistics Center$1
U01 · FY2021 · DK · contact PI
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center$3,207,131
U01 · FY2020 · DK · contact PI
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center$3,683,538
U01 · FY2019 · DK · contact PI
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center$4,666,612
U01 · FY2018 · DK · contact PI
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center$4,413,885
U01 · FY2017 · DK · contact PI
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center$4,003,647
U01 · FY2016 · DK · contact PI
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center$529,868
U01 · FY2016 · DK · contact PI
Diabetes Prevention Program Outcomes Study Follow-up$4,852,818
U01 · FY2015 · DK · contact PI
Diabetes Prevention Program Outcomes Study$2,595,589
U01 · FY2014 · DK · contact PI
Diabetes Prevention Program Outcomes Study$5,199,502
U01 · FY2013 · DK · contact PI
Diabetes Prevention Program Outcomes Study$1,729,000
U01 · FY2013 · DK · contact PI